Who Owns Pfizer?
On Nov. 9, Pfizer announced that its coronavirus vaccine is more than 90 percent effective. Who owns Pfizer and where is the company based?
Nov. 18 2020, Published 12:18 p.m. ET
On Nov. 9, Pfizer announced that its coronavirus vaccine is more than 90 percent effective. Pfizer is developing the experimental coronavirus vaccine candidate, BNT162b2, in collaboration with the German drugmaker BioNTech. But who owns Pfizer and where is the pharmaceutical company based?
Pfizer isn't the only company in the race to produce and distribute a coronavirus vaccine. On Nov. 16, Moderna announced that its coronavirus vaccine is more than 94 percent effective. Moderna’s and Pfizer’s late-stage trial success gives the world more hope in race to end the COVID-19 pandemic.
What is Pfizer?
Pfizer is an American multinational pharmaceutical company. It develops and produces medicines and vaccines for many medical disciplines, including oncology, cardiology, endocrinology, immunology, and neurology. Pfizer was ranked 57 on the 2018 Fortune 500 list of the largest U.S. companies by total revenue.
Pfizer’s products include the drug Lipitor, used to lower LDL blood cholesterol; Lyrica for neuropathic pain and fibromyalgia; Diflucan, an oral antifungal medication; Zithromax, an antibiotic; Viagra for erectile dysfunction; and Celebrex, an anti-inflammatory drug.
Is Pfizer a U.S. company?
Yes, Pfizer is a U.S. company headquartered in New York City. The pharma company was formed in 1849 by Charles Pfizer and Charles F. Erhart.
Who owns Pfizer?
According to CNN, 29.4 percent of the company's shares are owned by the general public, while 70.6 percent of its shares are owned by institutional investors. The top three owners of Pfizer are The Vanguard Group, SSgA Funds Management, and BlackRock Fund Advisors.
Who is Pfizer's CEO?
Albert Bourla is Pfizer's current chairman and CEO. Bourla has been working with the pharma company for over 25 years and has held various executive roles across Pfizer’s segments including Zoetis, the Oncology and Consumer Healthcare business, vaccines, and Pfizer Innovative Health. Prior to becoming the CEO, Bourla served as the COO in 2018 and the Group President of Pfizer Innovative Health from 2016 to 2017.
Bourla started his career at Pfizer in the Animal Health Division in Greece after he earned a doctorate in Veterinary Medicine from the Veterinary School of Aristotle University. Bourla’s estimated net worth is approximately $26.4 million.
How has Pfizer led in the COVID-19 vaccine race?
Pfizer is developing the coronavirus vaccine, BNT162b2, in collaboration with the German drugmaker BioNTech. On Nov. 9, Pfizer announced preliminary results from a late-stage trial. Pfizer said that its experimental vaccine is 90 percent effective in preventing COVID-19.
On Nov. 16, Moderna announced preliminary results from its phase 3 trials, which showed that the COVID-19 vaccine was over 94 percent effective. Russia also said that the preliminary results from phase 3 trials showed that the Sputnik V vaccine was 92 percent effective in preventing COVID-19.
Where does Pfizer manufacture its drugs?
Below is the list of Pfizer’s manufacturing sites in the U.S.
- Andover, Mass.
- Franklin, Ohio
- Kalamazoo, Mich.
- McPherson, Kans.
- Middleton, Wisc.
- Pearl River, N.Y.
- Rochester, Mich.
- Rocky Mount, N.C.
- Sanford, N.C.
- St Louis
